Medical devices, healthcare technology and the business of care
510(k) clearance · K261466

Alegria Flash MPO; Alegria Flash PR3; Alegria Flash GBM

Zeus Scientific · Decision date Aug 21, 2026

FDA DECISIONK261466

What did the FDA decide?

FDA records K261466 as a 510(k) premarket notification, with a decision dated Aug 21, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Immunology
Decision date
Aug 21, 2026

FDA source record

Regulatory record facts

Identifier
K261466
Regulatory pathway
510(k) premarket notification
Product code
MOB
Decision code
SESE
Decision date
Aug 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Test System, Antineutrophil Cytoplasmic Antibodies (Anca).

Product code
MOB
FDA device class
2

FDA decision timeline

  1. K261466 received

    Application receipt date recorded by FDA.

  2. K261466 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zeus Scientific

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Branchburg, NJ

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records